The ever‐increasing importance of cancer as a leading cause of premature death worldwide
2021/06/04 by Freddie Bray, Mathieu Laversanne, Elisabete Weiderpass +1 · 16 citations
Business, Management and Accounting · Health Professions · Medicine · #Cardiovascular Health and Risk Factors #Global Health Care Issues #Global Public Health Policies and Epidemiology
paper · pdf · doi:10.1002/cncr.33587
openalex publication_date 2021/06/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30
Abstract
The relative importance of cardiovascular disease (CVD) and cancer as leading causes of premature death are examined in this communication. CVD and cancer are now the leading causes in 127 countries, with CVD leading in 70 countries (including Brazil and India) and cancer leading in 57 countries (including China). Such observations can be seen as part of a late phase of an epidemiologic transition, taking place in the second half of the 20th century and the first half of the present one, in which the dominance of infectious diseases is progressively superseded by noncommunicable diseases. According to present ranks and recent trends, cancer may surpass CVD as the leading cause of premature death in most countries over the course of this century. Clearly, governments must factor in these transitions in developing cancer policies for the local disease profile.
Citations
Cited by
- Scorpion venom peptides: Molecular diversity, structural characteristics, and therapeutic use from channelopathies to viral infections and cancers
- Cancer statistics in China and United States, 2022: profiles, trends, and determinants
- Effectiveness of virtual reality in cancer patients undergoing chemotherapy. Systematic review
- Gut Microbiota–Related Biomarkers in Immuno-Oncology
- Global cancer mortality among children, adolescents, and young adults from 77 countries, 1990–2021: a global time-series analysis and modelling study
- Differential associations of cardiorenal-inflammatory markers with cardiac and cancer mortality in cancer survivors
- Designing magnetic graphene oxide-polymer nanocomposites for pH-responsive passive targeting of hydrophobic anticancer drug 5-fluorouracil for breast cancer therapy
- SI-PPC-induced modulation of heparin/heparanase binding affinity: a steered molecular dynamics approach
- Chronic Stress, Immune Suppression, and Cancer Occurrence: Unveiling the Connection using Survey Data and Predictive Models
- The effect of alcohol minimum unit pricing and cancer warning labels on cancer incidence and mortality in Canada: an epidemiological modelling study
- Advancements in the use of cancer nanovaccines: Comprehensive insights with focus on lung and colon cancer
- Insights into the Structural Patterns in Human Glioblastoma Cell Line SF268 Activity and ADMET Prediction of Curcumin Derivatives
- The role of natural language processing in improving cancer care: A scoping review with narrative synthesis
- Impact of exercise on health outcomes in people with cancer: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials
- Valid Property-Enhanced Contrastive Learning for Targeted Optimization & Resampling for Novel Drug Design
- Priority-Aware Clinical Pathology Hierarchy Training for Multiple Instance Learning
Related